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Brief Technique ReportsBridge to lung transplantation using short-term ambulatory
extracorporeal membrane oxygenationAbeel A. Mangi, MD, David P. Mason, MD, James J. Yun, MD, PhD, Sudish C. Murthy, MD, PhD, and
Gosta B. Pettersson, MD, PhD, Cleveland, OhioSevere respiratory failure refractory to mechanical ventilation
can occur in patients awaiting lung transplantation (LTx).
Use of extracorporeal membrane oxygen (ECMO) to bridge
these patients to LTx is associated with considerable morbid-
ity and mortality.1 Most techniques rely on femoral cannula-
tion, thereby immobilizing patients.2 This in turn can lead to
rapid deconditioning and predisposes patients to nosocomial
pneumonia, deep venous thrombosis, and muscle wasting.3
This case highlights the use of upper-extremity ECMO,
which was established without intubation in a critically ill
transplant candidate, allowed ambulation, and ultimately
served as a successful bridge to LTx.CLINICAL SUMMARY
A 34-year-old man presented with dyspnea and was diag-
nosed with usual interstitial pneumonitis. His lung function
was stable for the previous 3 years and then declined pre-
cipitously. This prompted referral to the Cleveland Clinic
for expedited LTx evaluation. On presentation, diagnostic
studies demonstrated a forced expiratory volume at 1 sec-
ond of 53% of predicted, diffusion lung capacity for carbon
monoxide of 13% of predicted, and arterial oxygen tension
of 60 mm Hg on 8 L/min of oxygen. Arterial oxygen desa-
turated quickly to 52% on a 6-minute walk. Right-sided
heart catheterization revealed a pulmonary arterial pressure
of 71/29 mm Hg. During the course of the workup, further
respiratory deterioration necessitated admission to the med-
ical intensive care unit with 100% high-flow oxygen and
bilevel positive-airway pressure support. Despite this,
oxygen saturations could be maintained at only 80%. The
patient was listed for urgent LTx with a lung allocation
score of 92.5.
Because of refractory hypoxemia, severe pulmonary
hypertension, and right ventricular dysfunction refractory to
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was raised.Therewas no patent foramenovale on echocardiog-
raphy. Consequently, the decision was made to place the
patient on peripheral ECMO using sedation and local anesthe-
sia. Veno-arterial ECMO was chosen over veno-venous to
unload his right ventricle and to prevent shunting through the
pulmonaryvasculature.Anupper-extremity approachwas cho-
sen to facilitate ambulation and maintain global fitness. In the
operating room, sudden hemodynamic instability necessitated
rapid institution of ECMO through the femoral vessels because
of easy access. With extracorporeal support instituted, expo-
sure of the left axillary vessels (in this right-handed patient)
was possible. An 18F venous cannula was placed into the right
atrium via the axillary vein for drainage, and arterial return was
established with a 14F arterial cannula. A Bio-Medicus 560
centrifugal pump (Medtronic, Inc, Minneapolis, MN) was
used with a QUADROX D membrane oxygenator (Maquet
Cardiovascular, Wayne, NJ), and flow of 3.7 L/min was
established.
Two days later, ECMO flows decreased to less than 2.0
L/min with a resultant decrease in the patient’s peripheral
oxygen saturation. The lack of chatter in the venous line
and high line pressures in the arterial line suggested an oc-
clusive process on the arterial side of the circuit. The patient
was urgently brought to the operating room for revision of
the arterial limb. The left arterial cannula was converted to
an 8-mm polyethylene terephthalate graft sewn and trans-
ferred to the right axillary artery, with marked improvement
in flows to as high as 4.5 L/min and 100% peripheral oxy-
gen saturation. The patient was regularly transferred out of
bed (Figure 1) and ambulated in the intensive care unit. The
patient was maintained on bilevel positive airway pressure
for the first day to prevent atelectasis, after which he was
placed on nasal cannula with intermittent incentive spirom-
etry. While the patient was on ECMO, thrombocytopenia
and a resultant hematoma in the right axillary cut-down
site developed, which eventually stabilized. After 3 days
of ECMO support, the patient underwent double LTx. The
patient was slow to wean from the ventilator and required
temporary tracheostomy on posttransplant day 14. In addi-
tion, his axillary hematoma site developed necrosis that
required operative debridement but was resolved with local
wound care. His tracheostomy was removed, and he was
discharged to a rehabilitation facility on postoperative day
31. Two years after transplant, he enjoys both excellent graft
function and quality of life.rdiovascular Surgery c Volume 140, Number 3 713
FIGURE 1. Patient out of bed and awake with ECMO support.
Brief Technique ReportsDISCUSSION
Bridging patients to LTx using ECMO support represents
maximal therapy for severe respiratory failure. These patients
are at high risk for nosocomial infection, particularly
ventilator-acquired pneumonia. In addition, immobilization
and ventilator dependence rapidly lead to diaphragmatic
weakness and global deconditioning.4,5 LTx in this setting
has been associated with poor survival.6 In an effort to avoid
these negative side effects and improve survival, we instituted
ECMO via the upper extremities to allow ambulation in a pa-
tient with severe respiratory failure but without intubation.
We showed that this is feasible, and our patient successfully
underwent transplantation.
There have been other reports of extracorporeal bridge to
LTx in nonintubated patients. However, a pumpless extracor-
poreal lung-assist device with access through the femoral ves-
sels for carbon dioxide clearance has been used in most cases,
leaving patients bedridden.7,8 Pumpless paracorporeal sup-
port has also been used in an ambulatory fashion with central
cannulation, although this requires sternotomy or thoracot-
omy.9 Although our technique requires a pump to provide
flow adequate for oxygenation, it avoids central cannulation
and can be instituted without general anesthesia. The tech-
nique is simple and reproducible. Our experience suggests
that arterial cannulation should preferably be performed
with a polyethylene terephthalate side graft to optimize
flow and prevent potential ischemic limb complications.CONCLUSIONS
Clearly, this technique has limitations. Although ambula-
tion with the circuit is feasible, it is cumbersome and714 The Journal of Thoracic and Cardiovascular Surgrequires multiple support personnel for safe mobilization.
Fortunately for this patient, donor organs became available
after only 3 days. Feasibility of this approach for long-
term support is not certain, although we were prepared to
continue this therapy for as long as necessary to obtain donor
lungs, precluding a major complication. Future innovations
might use a more compact and transportable pump or
a pumpless system. Finally, although the patient was bridged
to LTx without intubation, his postoperative course was still
long and complex, and it is not clear that his outcome was
better than if he had been intubated before transplantation.
He still required prolonged ventilatory support after trans-
plantation, reflecting the debilitating effects of severe respi-
ratory failure and the challenges that these high-risk patients
present. Future investigation will be required to identify the
optimal treatment strategy.References
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Thorac Surg. 2008;85:1202-5.Direct aortic access through right minithoracotomy for implantation
of self-expanding aortic bioprosthetic valvesGiuseppe Bruschi, MD,a Federico De Marco, MD,a Pasquale Fratto, MD,a Jacopo Oreglia, MD,a
Paola Colombo,MD, PhD,a Roberto Paino, MD,b Silvio Klugmann, MD,a and Luigi Martinelli, MD,a Milan,
ItalyFIGURE 1. Ascending aorta exposure via right minithoracotomy.The development of transcatheter aortic valve implantation
(TAVI) for the treatment of severe aortic stenosis (AS) offers
a viable option for patients at high risk or with contraindica-
tions for standard cardiac surgery.1 We report our experience
of a novel surgical approach using direct aortic access through
a right minithoracotomy for implanting a self-expanding
aortic valve bioprosthesis (CoreValve, Medtronic-CV Lux-
embourg S.a.r.l.).
CLINICAL SUMMARY
Patient 1 is an 83-year-old woman (height, 145 cm;
weight, 40 kg; body mass index, 19 kg/m2) with symptom-
atic severe AS and New York Heart Association class III
heart failure. She had a peak transvascular pressure gradient
of 130 mm Hg, an aortic valve area of 0.5 cm2, and an aortic
annulus of 18 mm.
Patient 2 is a 60-year-old woman (height, 151 cm; weight,
135 kg; body mass index, 59.2 kg/m2) with symptomatic se-
vere AS, New York Heart Association class III, and severe
bronchopneumopathy. The patient had a peak transvascular
pressure gradient of 137 mm Hg and an aortic valve area of
0.6 cm2.
According to our institutional protocol, the patients were
jointly evaluated by a cardiovascular team, and the final deci-
sion of eligibility for undergoing TAVI was made. The fem-
oral approach and axillary access were excluded because ofsmall vessel size. The transapical approach was deemed to
be suboptimal because of a small-sized left ventricle (LV)
and extreme LV hypertrophy (patient 1), and the difficulties
in the surgical approach and suboptimal angle between the
LVand the ascending aorta (patient 2). In these patients, there-
fore, we opted for the direct exposure of the ascending aorta
via a right anterior minithoracotomy. All patients signed in-
formed, written consent. The procedures were performed by
the cardiovascular team composed of interventional cardiolo-
gists, cardiac surgeons with expertise in hybrid procedures,
and cardiac anesthesiologists. The patients were under gen-
eral anesthesia and mechanical ventilation. A 5.0-cm incision
was made at the level of the second right anterior intercostal
space with a right internal thoracic artery-sparing procedure.
A soft-tissue rectractor and a small rib retractor (patient 2)
were used to access the pericardium (Figure 1). A temporary
pacing lead was advanced into the right ventricle, and a 6F
pigtail catheter was inserted for hemodynamic monitoring
and landmark aortic angiography. Heparin was administeredrdiovascular Surgery c Volume 140, Number 3 715
